Search

Your search keyword '"Daryaee F"' showing total 21 results

Search Constraints

Start Over You searched for: Author "Daryaee F" Remove constraint Author: "Daryaee F"
21 results on '"Daryaee F"'

Search Results

1. Correlation between different lipophilicity parameters and antimycobacterial activities of 2-hydroxyacetamides.

4. Evaluating the Impact of the Tyr158 p K a on the Mechanism and Inhibition of InhA, the Enoyl-ACP Reductase from Mycobacterium tuberculosis .

5. Discovery of Novel Bruton's Tyrosine Kinase PROTACs with Enhanced Selectivity and Cellular Efficacy.

6. Structure-Kinetic Relationship Studies for the Development of Long Residence Time LpxC Inhibitors.

7. Impact of Target Turnover on the Translation of Drug-Target Residence Time to Time-Dependent Antibacterial Activity.

8. Positron Emission Tomography Imaging of Staphylococcus aureus Infection Using a Nitro-Prodrug Analogue of 2-[ 18 F]F- p -Aminobenzoic Acid.

9. Correlating Drug-Target Residence Time and Post-antibiotic Effect: Insight into Target Vulnerability.

10. Pharmacokinetic-pharmacodynamic models that incorporate drug-target binding kinetics.

11. Positron Emission Tomography Imaging with 2-[ 18 F]F- p-Aminobenzoic Acid Detects Staphylococcus aureus Infections and Monitors Drug Response.

12. A quantitative mechanistic PK/PD model directly connects Btk target engagement and in vivo efficacy.

13. Rationalizing the Binding Kinetics for the Inhibition of the Burkholderia pseudomallei FabI1 Enoyl-ACP Reductase.

14. Evaluating the Contribution of Transition-State Destabilization to Changes in the Residence Time of Triazole-Based InhA Inhibitors.

15. The biodistribution of 5-[18F]fluoropyrazinamide in Mycobacterium tuberculosis-infected mice determined by positron emission tomography.

16. Correlating Drug-Target Kinetics and In vivo Pharmacodynamics: Long Residence Time Inhibitors of the FabI Enoyl-ACP Reductase.

17. Selectivity of Pyridone- and Diphenyl Ether-Based Inhibitors for the Yersinia pestis FabV Enoyl-ACP Reductase.

18. A Methyl 4-Oxo-4-phenylbut-2-enoate with in Vivo Activity against MRSA that Inhibits MenB in the Bacterial Menaquinone Biosynthesis Pathway.

19. Translating slow-binding inhibition kinetics into cellular and in vivo effects.

20. Synthesis of aminoquinoline-based aminoalcohols and oxazolidinones and their antiplasmodial activity.

21. Synthesis and evaluation of in vitro anti-tuberculosis activity of N-substituted glycolamides.

Catalog

Books, media, physical & digital resources